Literature DB >> 1541309

Serum alpha-1-acid glycoprotein and protein binding of disopyramide in patients with congestive heart failure.

A Nomura, H Yasuda, T Kobayashi, S Kishino, N Kohri, K Iseki, K Miyazaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1541309     DOI： 10.1007/bf00314931

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  6 in total

Review 1.  Drug binding to human alpha-1-acid glycoprotein in health and disease.

Authors:  J M Kremer; J Wilting; L H Janssen
Journal:  Pharmacol Rev       Date:  1988-03       Impact factor: 25.468

2.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 3.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

Review 4.  Pharmacokinetics in patients with cardiac failure.

Authors:  N L Benowitz; W Meister
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

Review 5.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

6.  Hydralazine and furosemide kinetics.

Authors:  A Nomura; H Yasuda; K Katoh; T Akimoto; K Miyazaki; T Arita
Journal:  Clin Pharmacol Ther       Date:  1982-09       Impact factor: 6.875
  6 in total
  1 in total

Review 1.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.